HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,406 | -7.1% | 11,391 | -11.7% | 0.17% | -6.7% |
| Q2 2023 | $1,098,476 | +74.7% | 12,902 | +69.8% | 0.18% | +79.0% |
| Q1 2023 | $628,734 | +0.2% | 7,598 | -4.7% | 0.10% | -6.5% |
| Q4 2022 | $627,312 | +11.0% | 7,976 | +4.4% | 0.11% | -7.0% |
| Q3 2022 | $565,000 | +15.5% | 7,638 | +1.7% | 0.12% | +21.1% |
| Q2 2022 | $489,000 | -38.2% | 7,509 | -40.0% | 0.10% | -33.1% |
| Q1 2022 | $791,000 | -34.1% | 12,514 | -44.7% | 0.14% | -33.0% |
| Q4 2021 | $1,201,000 | -10.6% | 22,648 | +19.1% | 0.21% | -16.2% |
| Q3 2021 | $1,343,000 | -3.6% | 19,021 | -9.0% | 0.25% | -1.6% |
| Q2 2021 | $1,393,000 | -3.9% | 20,897 | -49.7% | 0.26% | -27.2% |
| Q3 2014 | $1,450,000 | -1.0% | 41,525 | 0.0% | 0.35% | +4.4% |
| Q2 2014 | $1,465,000 | – | 41,525 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |